Trends in disease burden of ADHD in China from 1990 to 2019 based on GBD analysis.

Q3 Medicine

中南大学学报(医学版) Pub Date : 2024-07-28 DOI:10.11817/j.issn.1672-7347.2024.240010

Nan Zheng, Jun Tang, Kexin Duan, Juntao Zhao, Xiaomei Ren

{"title":"Trends in disease burden of ADHD in China from 1990 to 2019 based on GBD analysis.","authors":"Nan Zheng, Jun Tang, Kexin Duan, Juntao Zhao, Xiaomei Ren","doi":"10.11817/j.issn.1672-7347.2024.240010","DOIUrl":null,"url":null,"abstract":"Objectives: Attention deficit hyperactivity disorder (ADHD) has a significant impact on individual health and society. This study aims to analyze the disease burden of ADHD in China from 1990 to 2019 and make predictions to provide a basis for the formulation of corresponding prevention and control strategies by the government.Methods: Using data from Global Burden of Diseases (GBD) 2019 database, we described the changes in incidence, prevalence, and disability-adjusted life years (DALY) in China from 1990 to 2019. An autoregressive integrated moving average model (ARIMA) was used to predict the disease burden from 2020 to 2029.Results: From 1990 to 2019, the incidence, prevalence and DALY rates of ADHD all showed an upward trend, with standardized rates for males significantly higher than those for females. The age group of 5 to 9 years showed a higher incidence. Both prevalence and DALY rates peaked at ages 10 to 14, gradually declining with increasing age, although ADHD continues to impose a certain disease burden on adults. Prediction results indicate a slow decline in the standardized incidence rate of ADHD in China from 2020 to 2029, with standardized prevalence and standardized DALY rates showing a gradual increase from 2020 to 2025, followed by a decrease, potentially reaching 112.28/100 000, 2 070.03/100 000, and 25.41/100 000 by 2 029, respectively.Conclusions: ADHD is a condition that spans the entire lifespan, yet current recognition, diagnosis, and treatment of adult ADHD remain insufficient. It is recommended to focus on the early diagnosis and treatment of adult ADHD based on existing disease monitoring to mitigate the impact of the disease on patients and society.","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"49 9","pages":"1449-1455"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11814397/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中南大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.11817/j.issn.1672-7347.2024.240010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Attention deficit hyperactivity disorder (ADHD) has a significant impact on individual health and society. This study aims to analyze the disease burden of ADHD in China from 1990 to 2019 and make predictions to provide a basis for the formulation of corresponding prevention and control strategies by the government.

Methods: Using data from Global Burden of Diseases (GBD) 2019 database, we described the changes in incidence, prevalence, and disability-adjusted life years (DALY) in China from 1990 to 2019. An autoregressive integrated moving average model (ARIMA) was used to predict the disease burden from 2020 to 2029.

Results: From 1990 to 2019, the incidence, prevalence and DALY rates of ADHD all showed an upward trend, with standardized rates for males significantly higher than those for females. The age group of 5 to 9 years showed a higher incidence. Both prevalence and DALY rates peaked at ages 10 to 14, gradually declining with increasing age, although ADHD continues to impose a certain disease burden on adults. Prediction results indicate a slow decline in the standardized incidence rate of ADHD in China from 2020 to 2029, with standardized prevalence and standardized DALY rates showing a gradual increase from 2020 to 2025, followed by a decrease, potentially reaching 112.28/100 000, 2 070.03/100 000, and 25.41/100 000 by 2 029, respectively.

Conclusions: ADHD is a condition that spans the entire lifespan, yet current recognition, diagnosis, and treatment of adult ADHD remain insufficient. It is recommended to focus on the early diagnosis and treatment of adult ADHD based on existing disease monitoring to mitigate the impact of the disease on patients and society.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

中南大学学报(医学版) Medicine-Medicine (all)

CiteScore

1.00

自引率

0.00%

发文量

8237

期刊介绍： Journal of Central South University (Medical Sciences), founded in 1958, is a comprehensive academic journal of medicine and health sponsored by the Ministry of Education and Central South University. The journal has been included in many important databases and authoritative abstract journals at home and abroad, such as the American Medline, Pubmed and its Index Medicus (IM), the Netherlands Medical Abstracts (EM), the American Chemical Abstracts (CA), the WHO Western Pacific Region Medical Index (WPRIM), and the Chinese Science Citation Database (Core Database) (CSCD); it is a statistical source journal of Chinese scientific and technological papers, a Chinese core journal, and a "double-effect" journal of the Chinese Journal Matrix; it is the "2nd, 3rd, and 4th China University Excellent Science and Technology Journal", "2008 China Excellent Science and Technology Journal", "RCCSE China Authoritative Academic Journal (A+)" and Hunan Province's "Top Ten Science and Technology Journals". The purpose of the journal is to reflect the new achievements, new technologies, and new experiences in medical research, medical treatment, and teaching, report new medical trends at home and abroad, promote academic exchanges, improve academic standards, and promote scientific and technological progress.